YU7901A - Nova primena derivata taksoida - Google Patents

Nova primena derivata taksoida

Info

Publication number
YU7901A
YU7901A YU7901A YUP7901A YU7901A YU 7901 A YU7901 A YU 7901A YU 7901 A YU7901 A YU 7901A YU P7901 A YUP7901 A YU P7901A YU 7901 A YU7901 A YU 7901A
Authority
YU
Yugoslavia
Prior art keywords
new use
taxoid
taxoid derivatives
derivatives
relates
Prior art date
Application number
YU7901A
Other languages
English (en)
Inventor
Marie-Christine Bissery
Patricia Vrignaud
Simon Roberts
Clive Brealey
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98115401A external-priority patent/EP0982027A1/en
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of YU7901A publication Critical patent/YU7901A/sh
Publication of RS52011B publication Critical patent/RS52011B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Ovaj pronalazak se odnosi na novu primenu derivata taksoida. Preciznije, on se odnosi na dobivanje leka za lečenje abnormalne proliferacije ćelija u mozgu sisara uključujući čoveka.[The present invention relates to a new use of taxoid derivatives. It relates more precisely to a method for treating abnormal cell proliferation in the brain of mammals including men by administrating a taxoid derivative.
YU7901A 1998-08-17 1999-08-13 Nova primena derivata taksoida RS52011B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98115401A EP0982027A1 (en) 1998-08-17 1998-08-17 Taxoid derivatives for treating abnormal cell proliferation of the brain
US9958198P 1998-09-08 1998-09-08
PCT/EP1999/006291 WO2000009120A1 (en) 1998-08-17 1999-08-13 New use of taxoid derivatives

Publications (2)

Publication Number Publication Date
YU7901A true YU7901A (sh) 2003-12-31
RS52011B RS52011B (sr) 2012-04-30

Family

ID=26149540

Country Status (19)

Country Link
US (1) US6346543B1 (sh)
EP (1) EP1109547A1 (sh)
JP (1) JP5354762B2 (sh)
KR (1) KR100710533B1 (sh)
AU (1) AU766168B2 (sh)
BG (1) BG65365B1 (sh)
CA (1) CA2340921C (sh)
CZ (1) CZ293959B6 (sh)
EE (1) EE04903B1 (sh)
HU (1) HU230235B1 (sh)
ID (1) ID27545A (sh)
IL (1) IL141238A0 (sh)
ME (1) ME00533B (sh)
NO (1) NO327296B1 (sh)
NZ (1) NZ509965A (sh)
RS (1) RS52011B (sh)
SK (1) SK285212B6 (sh)
TR (1) TR200100557T2 (sh)
WO (1) WO2000009120A1 (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP1020188A1 (en) * 1999-01-13 2000-07-19 Aventis Pharma S.A. New use of taxoid derivatives
US6926898B2 (en) * 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
WO2002097038A2 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
WO2003059934A2 (en) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
KR101671537B1 (ko) 2008-08-11 2016-11-01 넥타르 테라퓨틱스 다분지형 중합체 알카노에이트 컨쥬게이트
AU2010310986A1 (en) 2009-10-29 2012-06-14 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
EP2791122B1 (en) 2011-12-13 2019-01-23 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same
WO2013117683A1 (en) * 2012-02-10 2013-08-15 Aventis Pharma S.A. New pediatric uses of cabazitaxel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2696459B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
TW467896B (en) 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
US5481018A (en) 1995-03-31 1996-01-02 The Dow Chemical Company Amino nitrile intermediate for the preparation of alanine diacetic acid
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides

Also Published As

Publication number Publication date
HUP0103748A2 (hu) 2002-04-29
SK285212B6 (sk) 2006-09-07
NZ509965A (en) 2003-09-26
KR100710533B1 (ko) 2007-04-23
EP1109547A1 (en) 2001-06-27
IL141238A0 (en) 2002-03-10
AU766168B2 (en) 2003-10-09
WO2000009120A8 (en) 2001-04-05
US6346543B1 (en) 2002-02-12
AU5741999A (en) 2000-03-06
CZ2001604A3 (en) 2001-06-13
BG105264A (en) 2001-11-30
ID27545A (id) 2001-04-12
JP2002522490A (ja) 2002-07-23
EE200100079A (et) 2002-08-15
JP5354762B2 (ja) 2013-11-27
KR20010085396A (ko) 2001-09-07
NO20010654D0 (no) 2001-02-07
CZ293959B6 (cs) 2004-08-18
CA2340921C (en) 2009-01-06
NO20010654L (no) 2001-02-07
RS52011B (sr) 2012-04-30
BG65365B1 (bg) 2008-04-30
SK2302001A3 (en) 2001-09-11
WO2000009120A1 (en) 2000-02-24
NO327296B1 (no) 2009-06-02
ME00533B (me) 2011-10-10
TR200100557T2 (tr) 2001-07-23
CA2340921A1 (en) 2000-02-24
HU230235B1 (hu) 2015-10-28
HUP0103748A3 (en) 2003-01-28
EE04903B1 (et) 2007-10-15

Similar Documents

Publication Publication Date Title
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
WO2000009120A8 (en) New use of taxoid derivatives
IL114294A0 (en) Sterol derivatives
DE60015070D1 (de) Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache
DE69914726D1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
GR3035774T3 (en) Substituted benzolactam compounds as substance p antagonists
IL172825A0 (en) Preparation of 1,3-diphenylprop-2-en-1-one derivatives
GR3019782T3 (en) Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
MXPA01003501A (es) Metodo para moderar el estres o tension de las plantas.
MY107354A (en) Substituted cyclohexenes as central nervous system agents
PL331321A1 (en) Treatment pf psychotic disorders
PL346113A1 (en) New use of taxoid derivatives
RO118794B1 (ro) Metodă de tratament a unor stări dependente de steroizii gonadici
IL139303A0 (en) Treatment of arthritis and other similar conditions
AU1930801A (en) Indole derivatives for the treatment of depression and anxiety
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
IL136225A0 (en) Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
EP0900085A4 (en) METHOD FOR TREATING EXCESSIVE AGGRESSIVITY
UA35854A (uk) Спосіб лікування приховано протікаючого силікотуберкульозу
UA36341A (uk) Спосіб лікування запальних процесів навколозубних тканин
UA67467A (en) Method for treating dyscirculatory encephalopathy
UA32288A (uk) Спосіб лікування дегенеративних і запальних процесів
UA32316A (uk) Спосіб лікування жінок з патологічним клімаксом